Determinants of antidementia drug prescription in patients older than 65: A latent class analysis.
Mathilde FrançoisJonathan SicsicNathalie Pelletier-FleuryPublished in: Pharmacoepidemiology and drug safety (2020)
Antidementia drugs were less likely to be prescribed for patients with poor health status. This result is encouraging for these frail patients who are more vulnerable to the adverse effects of treatments. At the same time, this result encourage targeting specifically patients in good health status for the use of a decision aid, in an attempt to limit prescriptions by involving patients and families.